As you can see, my portfolio has taken a sizeable hit. There are days where stocks go up and there are days where they go down just as much so I am not too worried about anything.
HIMS took a major hit dropping over 25% today.
What happened was, there was a shortage of Novo Nordisk's Ozempic and Wegovy but that has been resolved. HIMS was successful because they had their own version of Wegovy but if there is no shortage, there is no major need to use Hims and Hers' version.
They have surged a lot within recent weeks, but this was a major crash for them. They are set to report their earnings for Q4 on Monday.
I plan on holding this stock for a decent amount of time so although I am down quite a bit, I am not too worried about it.
I invested another $2,500 into this stock. My average purchase price is around $58.
Add comment
Comments